IART
Integra LifeSciences Holdings
NASDAQ: IART · HEALTHCARE · MEDICAL DEVICES
$10.54
+4.56% today
Updated 2026-04-30
Market cap
$785.61M
P/E ratio
—
P/S ratio
0.48x
EPS (TTM)
$-6.74
Dividend yield
—
52W range
$9 – $17
Volume
0.8M
Integra LifeSciences Holdings (IART) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-31.60%
Operating margin
12.40%
ROE
-39.90%
ROA
2.39%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $419.30M | $29.41M | 59.86% | 14.01% | 7.01% |
| 2007 | $550.46M | $33.47M | 61.00% | 12.22% | 6.08% |
| 2008 | $654.60M | $34.93M | 61.38% | 7.24% | 5.34% |
| 2009 | $682.49M | $50.95M | 64.11% | 14.33% | 7.47% |
| 2010 | $732.07M | $65.67M | 63.37% | 13.48% | 8.97% |
| 2011 | $780.08M | $27.99M | 61.65% | 7.04% | 3.59% |
| 2012 | $830.87M | $41.20M | 62.16% | 8.88% | 4.96% |
| 2013 | $836.21M | $-16.98M | 60.05% | -0.44% | -2.03% |
| 2014 | $928.30M | $34.00M | 62.00% | 7.06% | 3.66% |
| 2015 | $882.73M | $-3.52M | 63.01% | 9.02% | -0.40% |
| 2016 | $992.08M | $74.56M | 64.81% | 11.63% | 7.52% |
| 2017 | $1.19B | $64.74M | 63.35% | 3.77% | 5.45% |
| 2018 | $1.47B | $60.80M | 61.19% | 7.54% | 4.13% |
| 2019 | $1.52B | $50.20M | 62.79% | 6.18% | 3.31% |
| 2020 | $1.37B | $133.89M | 62.03% | 11.03% | 9.76% |
| 2021 | $1.54B | $169.07M | 61.24% | 12.79% | 10.96% |
| 2022 | $1.56B | $180.55M | 62.29% | 15.34% | 11.59% |
| 2023 | $1.54B | $67.74M | 57.39% | 7.23% | 4.39% |
| 2024 | $1.61B | $-6.94M | 54.77% | 1.76% | -0.43% |
| 2025 | $1.64B | $-516.47M | 51.69% | 4.18% | -31.58% |